epicur
FEBRUARY 23, 2023
Traditional 503A compounding pharmacies and 503B outsourcing manufacturers both serve as important partners for veterinary practices, providing patient-specific prescriptions and manufacturing bulk drugs for in-practice use and dispensing when allowed by state regulations.
epicur
NOVEMBER 26, 2024
How will you communicate Bova’s reputation to US veterinarians? Well, something unique Bova has done that not many compounders do, if any in the world, is a lot of work on research and development. Nick contacted several compounding pharmacies in the US and visited the Stokes and Epicur facilities multiple times.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
epicur
OCTOBER 29, 2024
Technicians spend a large portion of their time communicating with owners about the medications that have been prescribed and the best way to obtain and administer them. When touring their compounding facilities, being able to see the behind-the-scenes part of their process was eye-opening. Creativity is the key more often than not.
epicur
JANUARY 4, 2023
Compounding pharmacies, unlike 503Bs, are not required to test the final product. They know in certain states they can’t dispense products from a compounding pharmacy, or even keep them in stock, but Epicur is able to provide a product that they can actually start patient care with immediately. Thanks, Branson!
Quality Matters
AUGUST 3, 2023
While focuses on evaluating and establishing supplier reliability for pharmaceutical manufacturing companies and compounding pharmacies, its high-level elements of supplier qualification can also be applied to suppliers of foods and dietary supplement ingredients. Senior Director, General Chapters Global Science and Standards Division.
epicur
AUGUST 8, 2023
Watch our most recent on-demand GFI webinar with Nicole Clausen, What Every Inventory Manager Needs to Know About Compounded Medications. Impending USP Guidelines on Beyond-Use Dates Coming in late 2023, new USP guidelines will limit Beyond-Use Dates (BUDs) on drugs from 503A compounding pharmacies. Watch it On-Demand 2.
epicur
JULY 2, 2024
USP Guidelines The new USP Guidelines limit beyond-use dates (BUDs) for compounded drugs at all 503A compounding pharmacies. It’s exciting to be able to navigate through dozens of different decision-makers or layers of management and communicate our value proposition and why we are the best choice for them moving forward.
Expert insights. Personalized for you.
52 
Let's personalize your content